Sleep disorders and circadian clock disruption in Alzheimer’s disease and other dementias of aging
(R01 – Clinical Trial Not Allowed)
The NIA invites R01 applications proposing molecular, cellular, genetic, epigenetic, and systems biology approaches on the causes and consequences of sleep deficiency and circadian clock dysfunction in Alzheimer’s disease, and the potential role of sleep and circadian function as modifiers of neurodegenerative progression. View full details.
